Cancer Vaccine Week
Susan Hasty, Publisher
Table of Contents . . . April 10th, 2006
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Cancer Vaccine Week | Other Publications
Human Papillomavirus - Human papillomaviruses are genotyped by bead-based multiplex method
Human Papillomavirus - Study group urges establishment of international standard for HPV 16 antibodies
Human Papillomavirus Vaccine - Dendritic cell activation by HPV-16 vaccine involves a specific C-type lectin
Immunotherapy - Heat labile Escherichia coli enterotoxin is potential adjuvant for transcutaneous cancer immunotherapy
Apoptosis - Polyphenols purified from the aroeira plant induced apoptosis in DU145 cells
Apoptosis - Role of annexin A5 imaging in cancer treatment and surveillance explored
Apoptosis - Schisandrin B enhanced doxorubicin-induced apoptosis of cancer cells
Apoptosis - Studies add new findings to apoptosis body of knowledge
Breast Cancer - Findings advance knowledge in breast cancer research
Breast Cancer - Studies add new findings to breast cancer body of knowledge
Cancer Therapy - Studies add new findings to cancer therapy body of knowledge
Cancer Vaccines - Findings advance knowledge in cancer vaccines research
Cancer Vaccines - Researchers provide details of new studies and findings in the area of cancer vaccines
Cancer Vaccines - Researchers' work adds to cancer vaccines body of knowledge
Colorectal Cancer - Chemotherapy-induced colorectal cancer cell death inhibited by c-FLIP
Colorectal Cancer - Colorectal cancer did not show objective response when treated with capecitabine and thalidomide
Drug Development - Corroles are specifically delivered to tumor cells via noncovalent conjugates
Drug Development - Simplified ecteinascidin-saframycin analogs synthesized
Drug Development - Stilbenoids of Kobresia nepalensis exhibited DNA topoisomerase II inhibition
Drug Development - Structural basis for antitumor effect of aplyronine A studied
Esophageal Tumors - Hypoxic esophageal tumors responded to radiotherapy with addition of irinotecan
Finance - XOMA reports total 2005 revenues of $18.7 million, up from $3.7 million in 2004
Head & Neck Cancer - Head and neck squamous cell carcinoma treated by docetaxel, cisplatin, and 5-fluorouracil
Hepatocellular Carcinoma - Hepatocellular carcinoma treated by menatetrenone, a vitamin K2 analog
Leukemia - Adult T cell leukemia treated by curcumin
Leukemia - New findings in the area of leukemia described
Lung Cancer - Lung cancer treated by carboplatin/gemcitabine, an alternative therapy regimen
Lung Cancer - Lung cancer treated by irinotecan and cisplatin
Lung Cancer - Pharmacokinetics of amrubicin in lung cancer patients characterized
Lung Cancer - Quinuclidinone analogs examined as anti-proliferative agents in lung cancer
Lung Cancer - Reports describe recent advances in lung cancer research
Lung Cancer - Resected non-small cell lung cancer linked to extreme chemotherapy resistance
Melanoma - Impact of lymphoscintigraphy technique on outcome of sentinel node biopsy in melanoma discussed
Melanoma Vaccines - New data illuminates research in melanoma vaccines
Melanoma Vaccines - Recent studies add new data to melanoma vaccines research
Melanoma Vaccines - Reports add new data to melanoma vaccines research
Myeloma - Outcome of myeloma not improved with addition of valspodar
Nephroblastoma - Wilms tumor complicated by liver metastases linked to less favorable outcome
Ovarian Cancer - Mdr-1 polymorphism G2677T/A correlates with paclitaxel response in ovarian cancer
Personnel - Dr. Judith Hemberger joins ZymoGenetics board of directors
Prostate Cancer - Cell Genesys to present data from two GVAX cancer immunotherapy clinical trials
Prostate Cancer - Hormone-sensitive prostate cancer treated with zoledronic acid therapy
Soft Tissue Sarcomas - Soft tissue sarcoma should not be treated with gemcitabine as first-line chemotherapy
Transitional Cell Carcinoma - Transitional cell carcinoma treated by gemcitabine and paclitaxel second-line chemotherapy
Tumor Lysis Syndrome - Hyperuricemia corrected with reduced-dose rasburicase
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
